These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7767094)

  • 1. Coexistence of scleromyositis associated with PM-Scl antibody and myasthenia.
    Hausmanowa-Petrusewicz I; Blaszczyk M; JabloĊ„ska S
    Neuromuscul Disord; 1995 Mar; 5(2):145-7. PubMed ID: 7767094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Anti PM-Scl antibodies. Study of prevalence and of meaning].
    Gaudin C; Fortenfant F; Adoue D; Beyne-Rauzy O
    Rev Med Interne; 2006 Sep; 27(9):665-70. PubMed ID: 16797795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [PM-Scl antibody positive systemic sclerosis associated with inclusion-body myositis].
    Kim S; Genth E; Krieg T; Hunzelmann N
    Z Rheumatol; 2005 Oct; 64(7):499-502. PubMed ID: 16244833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Idiopathic inflammatory myopathies with anti-PM-Scl antibodies: case series and literature review].
    Marie I; Lahaxe L; Tiev K; Duval-Modeste AB; Vittecoq O; Levesque H; Jouen F
    Rev Med Interne; 2010 Aug; 31(8):540-4. PubMed ID: 20510485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The human exosome: an autoantigenic complex of exoribonucleases in myositis and scleroderma.
    Brouwer R; Pruijn GJ; van Venrooij WJ
    Arthritis Res; 2001; 3(2):102-6. PubMed ID: 11178117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum autoantibody to the nucleolar antigen PM-Scl. Clinical and immunogenetic associations.
    Oddis CV; Okano Y; Rudert WA; Trucco M; Duquesnoy RJ; Medsger TA
    Arthritis Rheum; 1992 Oct; 35(10):1211-7. PubMed ID: 1418007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [An unusual association: polymyositis, myasthenia gravis and thymoma].
    van Boekel V; Godoy JM; Menezes JM
    Arq Neuropsiquiatr; 1990 Dec; 48(4):505-14. PubMed ID: 2094201
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies directed to novel components of the PM/Scl complex, the human exosome.
    Brouwer R; Vree Egberts WT; Hengstman GJ; Raijmakers R; van Engelen BG; Seelig HP; Renz M; Mierau R; Genth E; Pruijn GJ; van Venrooij WJ
    Arthritis Res; 2002; 4(2):134-8. PubMed ID: 11879549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Co-existence of clinical and immunohistochemical features of polymyositis and myasthenia gravis].
    Iwatsubo T; Arahata K; Motoyoshi Y; Murayama S; Mannen T
    Rinsho Shinkeigaku; 1988 Aug; 28(8):913-8. PubMed ID: 3240629
    [No Abstract]   [Full Text] [Related]  

  • 10. Myositis-specific and myositis-associated autoantibodies in Indian patients with inflammatory myositis.
    Srivastava P; Dwivedi S; Misra R
    Rheumatol Int; 2016 Jul; 36(7):935-43. PubMed ID: 27193471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody-mediated membrane abnormalities in polymyositis: reduction of acetylcholine receptors by immunoglobulin.
    Pestronk A; Drachman DB
    Ann N Y Acad Sci; 1987; 505():357-67. PubMed ID: 3479931
    [No Abstract]   [Full Text] [Related]  

  • 12. Overlap myasthenic syndrome: combined myasthenia gravis and Eaton-Lambert syndrome.
    Oh SJ; Dwyer DS; Bradley RJ
    Neurology; 1987 Aug; 37(8):1411-4. PubMed ID: 3614671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoimmune targets of heart and skeletal muscles in myasthenia gravis.
    Suzuki S; Utsugisawa K; Yoshikawa H; Motomura M; Matsubara S; Yokoyama K; Nagane Y; Maruta T; Satoh T; Sato H; Kuwana M; Suzuki N
    Arch Neurol; 2009 Nov; 66(11):1334-8. PubMed ID: 19752287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of myasthenia gravis and polymyositis with neoplasia, infection and autoimmune disorders.
    Behan WM; Behan PO; Doyle D
    Acta Neuropathol; 1982; 57(2-3):221-9. PubMed ID: 6751015
    [No Abstract]   [Full Text] [Related]  

  • 15. A case of polymyositis complicated with myasthenic crisis.
    Yoshidome Y; Morimoto S; Tamura N; Kobayashi S; Tsuda H; Hashimoto H; Takasaki Y
    Clin Rheumatol; 2007 Sep; 26(9):1569-70. PubMed ID: 17047888
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical and immunogenetic features of patients with autoantibodies to the nucleolar antigen PM-Scl.
    Marguerie C; Bunn CC; Copier J; Bernstein RM; Gilroy JM; Black CM; So AK; Walport MJ
    Medicine (Baltimore); 1992 Nov; 71(6):327-36. PubMed ID: 1435228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Penicillamine induced polymyositis and dermatomyositis.
    Carroll GJ; Will RK; Peter JB; Garlepp MJ; Dawkins RL
    J Rheumatol; 1987 Oct; 14(5):995-1001. PubMed ID: 3501473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scleromyositis: a scleroderma/polymyositis overlap syndrome.
    Jablonska S; Blaszczyk M
    Clin Rheumatol; 1998; 17(6):465-7. PubMed ID: 9890673
    [No Abstract]   [Full Text] [Related]  

  • 19. Experimental autoallergic myositis, polymyositis and myasthenia gravis. Autoimmune muscle disease associated with immunodeficiency and neoplasia.
    Dawkins RL
    Clin Exp Immunol; 1975 Aug; 21(2):185-201. PubMed ID: 52425
    [No Abstract]   [Full Text] [Related]  

  • 20. The changing landscape of the clinical value of the PM/Scl autoantibody system.
    Mahler M; Fritzler MJ
    Arthritis Res Ther; 2009; 11(2):106. PubMed ID: 19351430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.